AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

www.abbvie.com

ALCMI

ALCMI is a nonprofit international consortium comprised of 25 of the world’s premier oncology research institutions. We partner with the top minds from the most respected medical facilities, providing financial support and access to a team of experts and staff to assist in launching and managing investigator-initiated trials. We bridge the gap between clinical research organizations (CROs) and site management organizations (SMOs), resulting in a streamlined, agile process for quickly funding and initiating lung cancer research projects.

www.alcmi.org

American Association For Cancer Research (AACR)

The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through: Research, Education, Communication, Collaboration, Science Policy and Advocacy, and Funding for Cancer Research. Through its programs and services, the AACR fosters research in cancer and related biomedical science, accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer, promotes science education and training, and advances the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.

www.aacr.org

American Society of Clinical Oncology (ASCO)

Representing more than 50,000 oncology professionals, ASCO unites the global oncology community to conquer cancer by turning groundbreaking science into life-saving care. Through trusted research, world-class meetings, and career-long support, we empower members across all disciplines to advance innovation, improve patient outcomes, and create a world where cancer is prevented or cured, and every survivor is healthy.

www.asco.org

Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.

www.amgen.com

AstraZeneca

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

www.astrazeneca.com

Bayer

Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.

www.bayer.com

BeOne Medicines

BioNTech

Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals.

www.biontech.com

Boehringer Ingelheim

We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches.

pro.boehringer-ingelheim.com/inoncology

Bristol Myers Squibb

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.

www.bms.com/ca/en

Caris Life Sciences

Caris Life Sciences® is a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Caris has created the large-scale, multi-modal database and computing capability needed to analyze and unravel the molecular complexity of disease.

www.carislifesciences.com

CORELINE

Coreline Soft is a global medical AI company specializing in CT-based quantitative imaging for early detection and precision diagnostics.
Recognized for leadership in lung cancer screening AI, it supports major national programs across Europe and Asia.
With global regulatory clearances and deployments, it is building an AI imaging platform for screening, diagnosis, and clinical decision support.

www.corelinesoft.com/en

Daiichi Sankyo

With a legacy of innovation since 1899 of scientific expertise and a presence in 32 countries, Daiichi Sankyo and its 19,700+ employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.

www.daiichisankyo.com

Eli Lilly and Company

Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.

www.lilly.com

Foundation Medicine

Foundation Medicine is a pioneer in molecular profiling for cancer, working to shape the future of clinical care and research. We collaborate with a broad range of partners across the cancer community and strive to set the standard for quality, scientific excellence, and regulatory leadership. Our deep understanding of cancer biology helps physicians make informed treatment decisions for their patients and empowers researchers to develop new medicines. We are driven to help our partners find answers and take action as we work to transform cancer care.

www.foundationmedicine.com

Gilead and Kite

Gilead and Kite are working to transform how cancer is treated. We are innovating with next-generation therapies, combinations, and technologies to deliver improved outcomes for people with cancer. We are purposefully building our oncology portfolio and pipeline to address the greatest gaps in care. From antibody-drug conjugate technologies and small molecules to cell therapy-based approaches, we are creating new possibilities for people with cancer.

www.gilead.com/science/therapeutic-areas/oncology

Global Lung Cancer Coalition

The Global Lung Cancer Coalition promotes global understanding of the burden of lung cancer and the right of patients to effective early detection, better treatment and supportive care. Serving as the international voice of lung cancer patients, the Global Lung Cancer Coalition is committed to improving disease outcomes for all.

www.lungcancercoalition.org

Guardant Health

ImmunityBio

ImmunityBio develops therapies and vaccines to defeat cancers and infectious diseases, going beyond checkpoint inhibitors to bolster the immune system to deliver durable, safe protection. ANKTIVA® is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates natural killer, T- and memory T cells for long-duration response. Learn more at www.Anktiva.com

anktiva.com

Intuitive

Intuitive advances minimally invasive care through robotic-assisted systems, bronchoscopy platforms, and data-driven solutions that help physicians optimize outcomes, improve care team and patient experiences, lower costs, and expand access to better care worldwide.

www.intuitive.com/en-us

Japan Lung Cancer Society (JLCS)

Founded in 1960, the Japan Lung Cancer Society (JLCS) is the largest academic group in Japan focused on lung cancer, bringing together more than 7,500 multidisciplinary members including physicians, researchers, and allied health. The JLCS actively encourages international collaboration, working closely with the IASLC, to exchange knowledge and enhance patient care globally. The JLCS remains dedicated to easing the impact of lung cancer and strives toward a future without the disease.

www.haigan.gr.jp/en

JNPMEDI

JNPMEDI is a Life Sciences Research, Development, and Commercialization company dedicated to serving pharmaceutical, biotech, and medical device companies. JNPMEDI focuses on enabling its client’s journey from ideation to financing, from financing to development, from development to clinical trials, and from clinical trials to realization with its own e-clinical solution.

www.jnpmedi.com/home

Johnson & Johnson

At Johnson & Johnson, our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter, less invasive and personalized. We use our expertise in Innovative Medicine to advance healthcare across the spectrum of diseases to deliver the breakthroughs of tomorrow.

www.jnj.com/innovativemedicine

MSD

At MSD, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, MSD is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.

www.msd.com

Natera

Signatera is a custom-built circulating tumor DNA (ctDNA) test for molecular residual disease (MRD) assessment and treatment monitoring and in patients previously diagnosed with cancer. Signatera’s performance has been clinically validated in multiple cancer types as well as for immunotherapy response monitoring.

www.natera.com/oncology

Nuvation Bio

Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment.

nuvationbio.com

Oncology Frontier

Parexel

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere.

www.parexel.com

Pfizer

Pharmacosmos

Pharmacosmos is a leading global company in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anaemia. Building on its foundational expertise in carbohydrate chemistry and cell cycle biology, the company develops innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.

pharmacosmos.com

PharmaMar

PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines. The Company is inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. PharmaMar is the world leader in marine medicinal discovery, development and innovation.

pharmamar.com

Plusman LLC

Plusman is a Tokyo-based AI company improving patient outcomes through diagnostic imaging built on mathematical modeling. Our portfolio includes Plus.Lung.Nodule, achieving 98.3% sensitivity in lung nodule detection, and chest X-ray AI. A clinical study on low-dose CT demonstrated 41% improvement in detection sensitivity, with non-specialists using Plus.Lung.Nodule outperforming unaided specialists.

plusmanllc.co.jp

Qure.ai

Qure.ai is a global AI company innovating diagnostic solutions in healthcare for early detection and care management. Qure’s solutions power early diagnosis in lung cancer to support clinicians and propel developments for the lifescience industries. The company empowers healthcare workers or health systems by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life.

www.qure.ai

Regeneron

Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and product candidates in development. Visit www.Regeneron.com to learn more.

www.regeneron.com

Revolution Medicines

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.

www.revmed.com

ROCHE

Founded in 1896 in Basel, Switzerland, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare.

www.roche.com

Scanlan International

For over a century, the Scanlan family has designed and manufactured the world’s finest surgical instrumentation. Scanlan® LEGACY Needle Holders and Forceps feature the Scan II™ ergonomic handle for controlled suturing performance. The Scanlan® VATS full line includes D’Amico Clamps, Biopsy Forceps, advanced dissectors, and decortication graspers for thoracic surgery and minimally invasive applications.

www.scanlaninternational.com

Summit Therapeutics Inc.

Summit is a biopharmaceutical company focused on addressing serious unmet medical needs. Ivonescimab is a potential first‑in‑class investigational bispecific antibody targeting PD‑1 and VEGF. Phase 3 studies are actively enrolling in NSCLC (NCT05899608, NCT06767514) and CRC (NCT07228832). Ivonescimab is investigational and not approved by any regulatory authority except China’s NMPA.

www.smmttx.com

Thermo Fisher Scientific